Securities Code: 002287
Securities Abbreviation: Qizheng Tibetan Medicine
Announcement Number: 2026-030
Tibet Qizheng Tibetan Medicine Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
The Company held the fifth meeting of the sixth Board of Directors and the fourth meeting of the sixth Supervisory Board on October 10, 2024, and October 28, 2024, respectively, as well as the fifth extraordinary general meeting of shareholders in 2024, to review and approve the proposal on the "2024 Employee Stock Ownership Plan (Revised Draft)" and related proposals. The sixth Board of Directors' tenth meeting was held on April 23, 2025, to approve the "2024 Employee Stock Ownership Plan (First Phase)." Details of the proposals can be found in the announcements published on October 11, 2024, October 29, 2024, and April 25, 2025, in the Securities Times and on the Giant Tide Information Network (http://www.cninfo.com.cn).
According to the China Securities Regulatory Commission's "Guiding Opinions on the Pilot Implementation of Employee Stock Ownership Plans by Listed Companies," the Shenzhen Stock Exchange's "Self-Regulatory Guidelines No. 1 for Listed Companies on the Main Board," and the relevant provisions of the "2024 Employee Stock Ownership Plan" (hereinafter referred to as "the 2024 Employee Stock Ownership Plan"), the lock-up period for the first phase of the employee stock ownership plan (hereinafter referred to as "the First Phase Employee Stock Ownership Plan") will expire on June 5, 2026. The relevant information regarding the expiration of the lock-up period is announced as follows: